scispace - formally typeset
Open AccessJournal ArticleDOI

IGF-1 enhances cell proliferation and survival during early differentiation of mesenchymal stem cells to neural progenitor-like cells

TLDR
It is suggested that IGF-1 has a crucial role in the differentiation of MSCs into neuronal lineage by enhancing the proliferation and reducing the apoptosis in the NPCs.
Abstract
There has been increasing interest recently in the plasticity of mesenchymal stem cells (MSCs) and their potential to differentiate into neural lineages. To unravel the roles and effects of different growth factors in the differentiation of MSCs into neural lineages, we have differentiated MSCs into neural lineages using different combinations of growth factors. Based on previous studies of the roles of insulin-like growth factor 1 (IGF-1) in neural stem cell isolation in the laboratory, we hypothesized that IGF-1 can enhance proliferation and reduce apoptosis in neural progenitor-like cells (NPCs) during differentiation of MSCs into NCPs. We induced MSCs differentiation under four different combinations of growth factors: (A) EGF + bFGF, (B) EGF + bFGF + IGF-1, (C) EGF + bFGF + LIF, (D) EGF + bFGF + BDNF, and (E) without growth factors, as a negative control. The neurospheres formed were characterized by immunofluorescence staining against nestin, and the expression was measured by flow cytometry. Cell proliferation and apoptosis were also studied by MTS and Annexin V assay, respectively, at three different time intervals (24 hr, 3 days, and 5 days). The neurospheres formed in the four groups were then terminally differentiated into neuron and glial cells. The four derived NPCs showed a significantly higher expression of nestin than was shown by the negative control. Among the groups treated with growth factors, NPCs treated with IGF-1 showed the highest expression of nestin. Furthermore, NPCs derived using IGF-1 exhibited the highest cell proliferation and cell survival among the treated groups. The NPCs derived from IGF-1 treatment also resulted in a better yield after the terminal differentiation into neurons and glial cells than that of the other treated groups. Our results suggested that IGF-1 has a crucial role in the differentiation of MSCs into neuronal lineage by enhancing the proliferation and reducing the apoptosis in the NPCs. This information will be beneficial in the long run for improving both cell-based and cell-free therapy for neurodegenerative diseases.

read more

Citations
More filters
Journal ArticleDOI

The role of Insulin-Like Growth Factor 1 (IGF-1) in brain development, maturation and neuroplasticity.

TL;DR: The role of IGF-1 in brain development is reviewed, followed by a detailed discussion of the role played by IGF in cellular neuroplasticity in the CNS.
Journal ArticleDOI

BDNF as a Promising Therapeutic Agent in Parkinson's Disease.

TL;DR: Evidence is focused on the evidence that increasing BDNF level due to gene modulation or physical exercise has a neuroprotective effect and could be considered as adjunctive therapy in PD.
Journal ArticleDOI

Biomarkers of postoperative delirium and cognitive dysfunction.

TL;DR: Application of integrated systems biology has the potential to reconstruct the underlying network of molecular mechanisms and help in the identification of prognostic and diagnostic biomarkers.
Journal ArticleDOI

The Roles of Insulin-Like Growth Factors in Mesenchymal Stem Cell Niche.

TL;DR: The importance of IGFs, IGF-1 and IGF-2, in development and in the MSC niche and how they affect the pluripotency or differentiation towards multiple lineages of the three germ layers are described.
Journal ArticleDOI

Mesenchymal stem cell therapy for the treatment of traumatic brain injury: progress and prospects.

TL;DR: In this article, a review of mesenchymal stem cells (MSC) after Traumatic Brain Injury (TBI) and its future direction is presented. But, MSC therapy has a few drawbacks including tumor formation, which can be avoided by the use of MSC-derived exosomes.
References
More filters
Journal ArticleDOI

Mesenchymal and haematopoietic stem cells form a unique bone marrow niche

TL;DR: It is demonstrated that mesenchymal stem cells (MSCs), identified using nestin expression, constitute an essential HSC niche component and are indicative of a unique niche in the bone marrow made of heterotypic stem-cell pairs.
Journal ArticleDOI

A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke.

TL;DR: Intravenous autologous MSCs transplantation was safe for stroke patients during long‐term follow‐up and may improve recovery after stroke depending on the specific characteristics of the patients.
Journal ArticleDOI

Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells.

TL;DR: The efficient conversion of human adult bone marrow stromal cells (hMSC) into a neural stem cell-like population (hmNSC, for human marrow-derived NSC-like cells) is described and it is demonstrated that individual hmNSCs are multipotent and retain the capacity to generate both glia and neurons.
Related Papers (5)
Trending Questions (1)
Can IGF-1 increase or enhance either cell growth or productivity in mammalian cells, including cell therapy cells??

IGF-1 enhances cell proliferation and survival in neural progenitor-like cells derived from mesenchymal stem cells, indicating its potential to increase cell growth and productivity in cell therapy applications.